Reduction of Strategic Shareholdings and Annual Review of Holding Appropriateness
First written in FY2019. 4 of 7 entries say "Advanced", first in FY2021. Latest entry: FY2026.
105 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the fiscal year, the number of shares decreased for 1 unlisted issue and 1 issue other than unlisted shares, and the total sale proceeds related to the decrease in the number of shares were ¥284 million.」
In connection with its policy of reducing cross-shareholdings, the company sold 1 unlisted issue and 1 listed issue and disclosed total sale proceeds of ¥284 million. - FY2025AdvancedAnnual report
「During the fiscal year, the number of shares decreased for 1 unlisted issue and 4 issues other than unlisted shares, and the total sale proceeds related to the decrease in the number of shares were ¥165 million.」
In connection with its policy of reducing cross-shareholdings, the company sold 4 listed issues and other holdings and disclosed total sale proceeds of ¥165 million. - FY2024AdvancedAnnual report
「(Issues whose number of shares decreased during the fiscal year) Unlisted shares 1 18」
In connection with its policy of reducing cross-shareholdings, the company sold 1 unlisted holding during the fiscal year and recorded sale proceeds of ¥18 million. - FY2022RestatedAnnual report
「We hold shares for policy purposes when this is deemed necessary for the medium- to long-term development of the Group, such as maintaining relationships with business partners and strengthening alliances. For holdings whose significance has declined, we will reduce our cross-shareholdings while engaging in dialogue with the issuing companies. For each individual holding, we carefully assess whether the purpose of holding it is appropriate and whether the benefits and risks associated with holding it, including dividends, transaction profits, and share-price fluctuations, are commensurate with the cost of capital, and the Board of Directors reviews annually whether the holding remains appropriate.」
The company continues its policy of reducing cross-shareholdings and having the Board of Directors review them annually, including by comparing them with the cost of capital. During the fiscal year, the number of shares held in 1 unlisted issue decreased. - FY2021AdvancedAnnual report
「During the fiscal year, the number of shares decreased for 1 unlisted issue, and the total sale proceeds related to the decrease in the number of shares were ¥493 million.」
In connection with its policy of reducing cross-shareholdings, the company sold 1 unlisted holding and recorded sale proceeds of ¥493 million. - FY2020RestatedAnnual report
「For each individual cross-shareholding, we carefully assess whether the purpose of holding it is appropriate and whether the benefits and risks associated with holding it, including dividends, transaction profits, and share-price fluctuations, are commensurate with the cost of capital, and the Board of Directors reviews annually whether the holding remains appropriate.」
The company continues to compare the benefits and risks of cross-shareholdings with the cost of capital and have the Board of Directors review them annually. - FY2019First statedAnnual report
「We hold shares for policy purposes when this is deemed necessary for the medium- to long-term development of the Nisshin Seifun Group, such as maintaining relationships with business partners and strengthening alliances. For holdings whose significance has declined, we will reduce our cross-shareholdings while engaging in dialogue with the issuing companies. For each individual holding, the Board of Directors conducts an annual review of whether the purpose of holding it remains appropriate and whether the benefits and risks associated with the holding are commensurate with the cost of capital.」
The company has stated for the first time its policy of reducing holdings whose significance has declined and having the Board of Directors annually review whether each holding remains appropriate, including by comparing its benefits and risks with the cost of capital.